AKANDA CORP.
No SEC Form 4 filings for $AKAN in the last 30 days.
Akanda received a non-compliance letter from Nasdaq related to its market value of publicly held shares falling below the minimum $5 million requirement. The company has 180 calendar days to regain compliance. Following the announcement, Akanda's shares experienced a significant decline, dropping 14%.
This article details the intraday movements of 12 health care stocks on Thursday, highlighting both gainers and losers. Notable gainers include Agape ATP, Akanda, and Co-Diagnostics, with significant percentage increases, while stocks like WORK Medical Tech Gr, Wellgistics Health, and Indaptus Therapeutics experienced declines. The article provides market cap and recent earnings report dates for several of the mentioned companies.
Akanda Corp. has delayed its 2025 Annual Report on Form 20-F due to complexities arising from significant operational changes, including the liquidation of its UK cannabis business and the acquisition of a Mexican telecom asset. Despite higher operating expenses, the company saw revenues of $258,075 in 2025 from its new telecom assets and slightly narrowed its net loss. Akanda has committed to filing the report within the 15-day grace period.
